{"id":53841,"date":"2023-02-13T11:03:52","date_gmt":"2023-02-13T10:03:52","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/"},"modified":"2023-02-13T11:03:52","modified_gmt":"2023-02-13T10:03:52","slug":"global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/","title":{"rendered":"Global Targeted Sequencing Market Report 2022 to 2032: Featuring MedGenome, Novogene, PacBio. Paragon Genomics and PerkinElmer Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.researchandmarkets.com%2Freports%2F5734387%2Ftargeted-sequencing-market-global-regional%3Futm_source%3DBW%26utm_medium%3DPressRelease%26utm_code%3Dwwsfkg%26utm_campaign%3D1819090%2B-%2BGlobal%2BTargeted%2BSequencing%2BMarket%2BReport%2B2022%2Bto%2B2032%253a%2BFeaturing%2BMedGenome%252c%2BNovogene%252c%2BPacBio.%2BParagon%2BGenomics%2Band%2BPerkinElmer%2BAmong%2BOthers%26utm_exec%3Djamu273prd&amp;esheet=53316882&amp;newsitemid=20230213005268&amp;lan=en-US&amp;anchor=%26quot%3BTargeted+Sequencing+Market+-+A+Global+and+Regional+Analysis%3A+Focus+on+Product+Type%2C+Target+Enrichment+Method%2C+Type+of+Target+Capture%2C+Application%2C+End+User%2C+and+Region+Analysis+-+Analysis+and+Forecast%2C+2022-2032%26quot%3B&amp;index=1&amp;md5=a1d3ffff47afaa800b8c6b97b72c9c95\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Targeted Sequencing Market &#8211; A Global and Regional Analysis: Focus on Product Type, Target Enrichment Method, Type of Target Capture, Application, End User, and Region Analysis &#8211; Analysis and Forecast, 2022-2032&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230213005268\/en\/1711609\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230213005268\/en\/1711609\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global targeted sequencing market is projected to reach $10,976.1 million by 2032 from $3,198.8 million in 2022, growing at a CAGR of 13.12% during the forecast period 2022-2032.\n<\/p>\n<p>\nThe growth in the global targeted sequencing market is expected to be driven by the increased use of targeted sequencing in clinical laboratories and diagnostic applications, especially in cancer research.\n<\/p>\n<p>\nTargeted sequencing is a cost-effective and rapid way to detect novel and known variants in selected genetic or genomic regions. There are several different methods of DNA\/RNA sequencing depending on the scale of the region being sequenced.\n<\/p>\n<p>\nNext-generation sequencing (NGS) is the most used method for targeted sequencing, which offers good scalability, speed, and resolution to evaluate the targeted regions of interest. Other methods include sanger sequencing and CRISPR.\n<\/p>\n<p>\nThe major advantage of targeted sequencing as compared to whole genome sequencing is the smaller and more manageable data sets created, which are significantly easier to analyze.\n<\/p>\n<p>\nTargeted next-generation sequencing focuses on specific genomic areas of interest, which is ideal for examining specific pathways or targeted resequencing. Furthermore, it is more rapid and cost-effective as compared to whole genome sequencing and allows deeper sequencing. This is a powerful and especially sensitive method of identifying gene mutations and variants, including rare variants.\n<\/p>\n<p>\n<strong>Recent Developments in Global Targeted Sequencing Market<\/strong>\n<\/p>\n<ul>\n<li>\nIn August 2022, QIAGEN N.V. launched its QIAseq targeted DNA pro panels and the QIAseq UPXome RNA library kit as an expansion of its next-generation sequencing (NGS) portfolio. Both these launches lead to the growth of the company&#8217;s sequencing product portfolio.\n<\/li>\n<li>\nIn September 2022, BGI Group (MGI Tech Co., Ltd.) launched its DNBSEQ-G99, which is a mid to low-range throughput sequencer. This makes this sequencer especially suitable for targeted gene sequencing, small gene sequencing, and high and rapid-quality data output.\n<\/li>\n<li>\nIn June 2022, Agilent Technologies, Inc. announced its collaboration with the Amazon Elastic Compute Cloud (Amazon EC2) G5g powered by Amazon Web Services (AWS) Graviton2 processors. The NVIDIA T4G Tensor Core GPUs, combined with NVIDIA Clara Parabricks&#8217; advanced genomics capabilities, improved Agilent Technologies, Inc.&#8217;s cloud-native Alissa Reporter software. This collaboration is expected to streamline the company&#8217;s SureSelect family NGS assays, which comprise a wide range of custom and catalog panels.\n<\/li>\n<li>\nIn June 2022, Danaher. (Integrated DNA Technologies, Inc.) made an agreement with Beckman Coulter, Inc. Life Sciences for the distribution of its Biomek NGenius Next Generation Sequencing Library Prep System. This deal helped make high-performance NGS solutions more accessible to laboratories.\n<\/li>\n<\/ul>\n<p>\n<strong>Market Dynamics<\/strong>\n<\/p>\n<p>\n<em><strong>Drivers<\/strong><\/em>\n<\/p>\n<ul>\n<li>\nRising Need for Sequencing at Greater Depth\n<\/li>\n<li>\nLower Cost and Data Burden of Targeted Sequencing When Compared to Whole Genome Sequencing\n<\/li>\n<li>\nIncrease in Cancer Prevalence\n<\/li>\n<\/ul>\n<p>\n<em><strong>Challenges<\/strong><\/em>\n<\/p>\n<ul>\n<li>\nLack of Knowledge About New Genes and Biomarkers\n<\/li>\n<li>\nLack of High Complexity Genomic Testing Centers in High Potential Markets\n<\/li>\n<\/ul>\n<p>\n<em><strong>Opportunities<\/strong><\/em>\n<\/p>\n<ul>\n<li>\nIncreasing Use in Clinical Research and Trials for Better Disease Pathogenesis and\/or Clinical Relevance\n<\/li>\n<li>\nRising Adoption of Targeted Sequencing in Targeted Therapeutics\n<\/li>\n<\/ul>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAgilent Technologies, Inc.\n<\/li>\n<li>\nAzenta US, Inc. (GENEWIZ)\n<\/li>\n<li>\nBGI Group (MGI Tech Co. Ltd.)\n<\/li>\n<li>\nCD Genomics\n<\/li>\n<li>\nDaicel Corporation (Daicel Arbor Biosciences)\n<\/li>\n<li>\nDanaher. (Integrated DNA Technologies, Inc.)\n<\/li>\n<li>\nF. Hoffmann-La Roche Ltd.\n<\/li>\n<li>\nIllumina, Inc.\n<\/li>\n<li>\nLGC Limited (LGC Biosearch Technologies)\n<\/li>\n<li>\nMedGenome\n<\/li>\n<li>\nNovogene Co. Ltd.\n<\/li>\n<li>\nPacBio\n<\/li>\n<li>\nParagon Genomics, Inc.\n<\/li>\n<li>\nPerkinElmer Inc.\n<\/li>\n<li>\nPsomagen\n<\/li>\n<li>\nQIAGEN N.V.\n<\/li>\n<li>\nSage Science, Inc.\n<\/li>\n<li>\nTakara Bio Inc.\n<\/li>\n<li>\nTecan Trading AG\n<\/li>\n<li>\nThermo Fisher Scientific Inc.\n<\/li>\n<li>\nTwist Bioscience\n<\/li>\n<li>\nZymo Research Corporation\n<\/li>\n<\/ul>\n<p>\n<strong>Market Segmentation<\/strong>\n<\/p>\n<p>\n<strong>Segmentation 1: by Product Type<\/strong>\n<\/p>\n<ul>\n<li>\nInstruments\n<\/li>\n<li>\nKits\/Panels and Assays\n<\/li>\n<li>\nServices\n<\/li>\n<li>\nOther Product Types\n<\/li>\n<\/ul>\n<p>\n<strong>Segmentation 2: by Target Enrichment Method<\/strong>\n<\/p>\n<ul>\n<li>\nHybridization Capture\n<\/li>\n<li>\nAmplicon Sequencing\n<\/li>\n<li>\nOther Target Enrichment Methods\n<\/li>\n<\/ul>\n<p>\n<strong>Segmentation 3: by Type of Target Capture<\/strong>\n<\/p>\n<ul>\n<li>\nTargeted DNA Sequencing\n<\/li>\n<li>\nTargeted RNA Sequencing\n<\/li>\n<li>\nOther Types of Target Capture\n<\/li>\n<\/ul>\n<p>\n<strong>Segmentation 4: by Application<\/strong>\n<\/p>\n<ul>\n<li>\nOncology\n<\/li>\n<li>\nReproductive Health\n<\/li>\n<li>\nHereditary Diseases\n<\/li>\n<li>\nNeurological Disorders\n<\/li>\n<li>\nInfectious Diseases\n<\/li>\n<li>\nCardiovascular Diseases\n<\/li>\n<li>\nRare Diseases\n<\/li>\n<li>\nOther Applications\n<\/li>\n<\/ul>\n<p>\n<strong>Segmentation 5: by End User<\/strong>\n<\/p>\n<ul>\n<li>\nDiagnostic and Clinical Laboratories\n<\/li>\n<li>\nAcademic and Research Institutions\n<\/li>\n<li>\nPharmaceutical and Biotech Companies\n<\/li>\n<li>\nOther End Users\n<\/li>\n<\/ul>\n<p>\n<strong>Segmentation 6: by Region<\/strong>\n<\/p>\n<ul>\n<li>\nNorth America\n<\/li>\n<li>\nEurope\n<\/li>\n<li>\nAsia-Pacific\n<\/li>\n<li>\nLatin America\n<\/li>\n<li>\nRest-of-the-World (RoW)\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.researchandmarkets.com%2Freports%2F5734387%2Ftargeted-sequencing-market-global-regional%3Futm_source%3DBW%26utm_medium%3DPressRelease%26utm_code%3Dwwsfkg%26utm_campaign%3D1819090%2B-%2BGlobal%2BTargeted%2BSequencing%2BMarket%2BReport%2B2022%2Bto%2B2032%253a%2BFeaturing%2BMedGenome%252c%2BNovogene%252c%2BPacBio.%2BParagon%2BGenomics%2Band%2BPerkinElmer%2BAmong%2BOthers%26utm_exec%3Djamu273prd&amp;esheet=53316882&amp;newsitemid=20230213005268&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.researchandmarkets.com%2Fr%2F3eo20n&amp;index=2&amp;md5=ba601a9fb9bb50d13f30f046290a184f\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/3eo20n<\/a>\n<\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong>\n<\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;&#x74;&#111;&#x3a;p&#x72;&#x65;&#115;&#x73;&#64;&#x72;&#x65;&#115;&#x65;a&#x72;&#x63;&#104;&#x61;n&#x64;&#x6d;&#97;&#x72;k&#x65;&#x74;&#115;&#x2e;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;r&#x65;s&#x73;&#64;&#x72;e&#x73;&#101;&#x61;&#114;&#x63;&#104;&#x61;&#110;d&#109;a&#x72;k&#x65;t&#x73;&#46;&#x63;&#111;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Targeted Sequencing Market &#8211; A Global and Regional Analysis: Focus on Product Type, Target Enrichment Method, Type of Target Capture, Application, End User, and Region Analysis &#8211; Analysis and Forecast, 2022-2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global targeted sequencing market is projected to reach $10,976.1 million by 2032 from $3,198.8 &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53841","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Targeted Sequencing Market Report 2022 to 2032: Featuring MedGenome, Novogene, PacBio. Paragon Genomics and PerkinElmer Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Targeted Sequencing Market Report 2022 to 2032: Featuring MedGenome, Novogene, PacBio. Paragon Genomics and PerkinElmer Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Targeted Sequencing Market &#8211; A Global and Regional Analysis: Focus on Product Type, Target Enrichment Method, Type of Target Capture, Application, End User, and Region Analysis &#8211; Analysis and Forecast, 2022-2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global targeted sequencing market is projected to reach $10,976.1 million by 2032 from $3,198.8 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-13T10:03:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230213005268\/en\/1711609\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Targeted Sequencing Market Report 2022 to 2032: Featuring MedGenome, Novogene, PacBio. Paragon Genomics and PerkinElmer Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2023-02-13T10:03:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\\\/\"},\"wordCount\":798,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230213005268\\\/en\\\/1711609\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\\\/\",\"name\":\"Global Targeted Sequencing Market Report 2022 to 2032: Featuring MedGenome, Novogene, PacBio. Paragon Genomics and PerkinElmer Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230213005268\\\/en\\\/1711609\\\/21\\\/logo.jpg\",\"datePublished\":\"2023-02-13T10:03:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230213005268\\\/en\\\/1711609\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230213005268\\\/en\\\/1711609\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Targeted Sequencing Market Report 2022 to 2032: Featuring MedGenome, Novogene, PacBio. Paragon Genomics and PerkinElmer Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Targeted Sequencing Market Report 2022 to 2032: Featuring MedGenome, Novogene, PacBio. Paragon Genomics and PerkinElmer Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Targeted Sequencing Market Report 2022 to 2032: Featuring MedGenome, Novogene, PacBio. Paragon Genomics and PerkinElmer Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Targeted Sequencing Market &#8211; A Global and Regional Analysis: Focus on Product Type, Target Enrichment Method, Type of Target Capture, Application, End User, and Region Analysis &#8211; Analysis and Forecast, 2022-2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global targeted sequencing market is projected to reach $10,976.1 million by 2032 from $3,198.8 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-13T10:03:52+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230213005268\/en\/1711609\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Targeted Sequencing Market Report 2022 to 2032: Featuring MedGenome, Novogene, PacBio. Paragon Genomics and PerkinElmer Among Others &#8211; ResearchAndMarkets.com","datePublished":"2023-02-13T10:03:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/"},"wordCount":798,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230213005268\/en\/1711609\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/","name":"Global Targeted Sequencing Market Report 2022 to 2032: Featuring MedGenome, Novogene, PacBio. Paragon Genomics and PerkinElmer Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230213005268\/en\/1711609\/21\/logo.jpg","datePublished":"2023-02-13T10:03:52+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230213005268\/en\/1711609\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230213005268\/en\/1711609\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-targeted-sequencing-market-report-2022-to-2032-featuring-medgenome-novogene-pacbio-paragon-genomics-and-perkinelmer-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Targeted Sequencing Market Report 2022 to 2032: Featuring MedGenome, Novogene, PacBio. Paragon Genomics and PerkinElmer Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53841","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53841"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53841\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53841"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53841"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53841"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}